WELLINGTON MANAGEMENT GROUP LLP - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 1 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$10,758,000
-91.3%
533,604
-83.8%
0.00%
-90.0%
Q2 2021$123,132,000
+11.4%
3,299,353
-23.6%
0.02%
+5.3%
Q1 2021$110,486,000
+16.2%
4,320,900
+0.1%
0.02%
+5.6%
Q4 2020$95,116,000
+8.0%
4,317,623
-11.8%
0.02%0.0%
Q3 2020$88,081,000
-20.1%
4,896,153
+12.8%
0.02%
-28.0%
Q2 2020$110,291,000
+55.1%
4,342,169
+12.2%
0.02%
+31.6%
Q1 2020$71,092,000
+1104.7%
3,870,016
+1345.0%
0.02%
+1800.0%
Q4 2019$5,901,000
+194.2%
267,824
-59.9%
0.00%0.0%
Q2 2016$2,006,000
-81.9%
668,691
-67.6%
0.00%
-66.7%
Q1 2016$11,075,000
-61.6%
2,066,147
-15.0%
0.00%
-62.5%
Q4 2015$28,857,000
+39.2%
2,431,157
-3.7%
0.01%
+33.3%
Q3 2015$20,732,000
-40.7%
2,525,168
+0.8%
0.01%
-33.3%
Q2 2015$34,939,000
-41.5%
2,504,522
+0.8%
0.01%
-40.0%
Q1 2015$59,734,000
+139.3%
2,485,847
+64.0%
0.02%
+114.3%
Q4 2014$24,957,0001,515,3020.01%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 4,080,237$74,954,00012.68%
Aquilo Capital Management, LLC 1,237,379$22,731,0008.86%
EcoR1 Capital, LLC 3,346,301$61,472,0006.42%
RTW INVESTMENTS, LP 6,963,135$127,913,0005.51%
BRIDGER MANAGEMENT, LLC 1,679,344$30,850,0003.57%
Parkman Healthcare Partners LLC 300,805$5,526,0002.56%
ACUTA CAPITAL PARTNERS, LLC 256,500$4,712,0002.28%
Integral Health Asset Management, LLC 185,000$3,398,0001.50%
DAFNA Capital Management LLC 147,714$2,714,0001.13%
EAM Global Investors LLC 88,465$1,625,0000.95%
View complete list of DICERNA PHARMACEUTICALS INC shareholders